At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
NCT ID: NCT01931644
Last Updated: 2024-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
17667 participants
OBSERVATIONAL
2013-07-31
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
NCT04806620
Study of Systemic Lupus Erythematosus
NCT00001372
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
NCT07128966
Clinical Autoinflammatory Disease Cohort
NCT07126145
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
NCT04018222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health Condition
Collect blood and other optional biospecimens from participants with a diagnosed health condition
No interventions assigned to this group
Healthy Control
Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide proof of diagnosis
* Live in USA
Exclusion Criteria
* Receipt of blood products within 30 days of study blood collection
* Receipt of investigational drug within 30 days of study blood collection
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanguine Biosciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Houman Hemmati, MD
Role: PRINCIPAL_INVESTIGATOR
Sanguine Biosciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sanguine Biosciences
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAN-BB-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.